tiprankstipranks
Trending News
More News >

Transcode Therapeutics announces 1-for-28 reverse stock split

TransCode Therapeutics (RNAZ) announced that its Board of Directors has approved a 1-for-28 reverse stock split. The reverse stock split was approved by TransCode’s stockholders on May 2, and is intended to increase the per share trading price of the company’s common stock to enable the company to satisfy the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The effective date of the reverse stock split has not yet been determined and will be announced by the company at least two business days prior to its implementation.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue